News
IDIBELL renews the accreditation “Excellence in Human Resources” of the European Commission
The Human Resources Strategy for Researchers (HRS4R) supports institutions and research centers in the implementation of human resources initiatives that promote the researchers’ attraction and the development of the research career.
The forerunner of IDIBELL Dr. Miquel Rutllant has died
On December 26, Dr. Miquel Rutllant left us. He was a key person in the creation of what we now know as IDIBELL and one of the forerunners of biomedical research in our country.
What are the genetic reasons behind resistance to COVID-19?
It is proven that SARS-CoV-2 infection manifests in very different ways: some cases simply show mild discomfort for a few days, others need to be admitted to the ICU and some others even go through it without experiencing any kind of symptom. There are also cases where a person, despite having been living with a […]
The innovation in science education project STARS GAME implements the first version of its escape room game in four high schools in L’Hospitalet
STARS GAME is a 3-year project that revolves around the co-creation of a digital escape room, in which both the students collective (between 10 and 13 years old) participate, through classroom workshops, together with faculty and scientific research and also communication professionals from the four countries
An IDIBELL project on rehabilitation of people with facial paralysis is promoted by Sinergia Innova
Sinergia Innova is an initiative of the L’Hospitalet City Council to promote open innovation in the biomedical sector.
We close a 2021 full of science!
When the year ends it is a good time to look back and review the challenges achieved in the last twelve months. More than 1,300 scientific articles, of which 550 are led by IDIBELL, show that there many objectives have been achieved, but there are also many questions that remain to be answered.
Finding new paths in the treatment of cystic fibrosis
A research group from IDIBELL has identified genes relevant to the oxidative stress response that could help design new treatments for cystic fibrosis.
Immunotherapy with genetically modified immune cells increases survival of patients with aggressive B lymphoma who do not respond to chemotherapy
Two studies published in The New England Journal of Medicine, with the participation of IDIBELL and the ICO, present the results of two phase 3 clinical trials comparing treatment with CART lymphocytes versus conventional treatment with chemotherapy and bone marrow transplantation.
Scientists identify two genes involved in the cerebral effects of boys and girls with obsessive-compulsive symptoms
A team from IDIBELL, the Bellvitge University Hospital and CIBERSAM, in collaboration with ISGlobal and Harvard Medical School, have described alterations in two genes that would explain the abnormally reverberant behavior of the brain circuits involved in OCD.